Pfizer, GSK Pentavalent Meningococcal Vaccine Recommendations Should Be Harmonized, ACIP Says

The US CDC committee appears on track to recommend GSK’s five-in-one vaccine when use of both a quadrivalent vaccine and a separate meningitis B vaccine are indicated at the same visit, the approach adopted for Pfizer’s Penbraya.